This edition of ReFlections offers essential reading on two very timely topics - insurance considerations given the changing status of HIV/AIDS and the use of patient-generated health data. This issue also describes new investigations supported by the Longer Life Foundation, RGA's joint foundation with Washington University School of Medicine in St. Louis.
Around 2.5 million people in Europe are living with HIV.1 The overall prevalence is 0.3% compared to 5% in Sub-Saharan Africa.2 Most European countries have been working to combat the HIV epidemic since the early 1980s. As a result, mortality from AIDS in Europe has steadily decreased since 2001.3 But does this mean that the crisis is really over? And what does this imply for the insurance industry?